Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/13768
Title: Temozolomide-associated liver fibrosis
Authors: Parakh, Sagun;Hamid, Anis A;Cher, Lawrence M;Gan, Hui K
Affiliation: Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia
Issue Date: Nov-2016
EDate: 2016-04-20
Citation: The Journal of Clinical Pharmacology 2016; 56(11): 1448-1449
Abstract: Temozolomide is generally well tolerated and severe hepatic toxicities associated with temozolomide are rare. We report a case of liver fibrosis in a patient on temozolomide for the treatment of GBM. This article is protected by copyright. All rights reserved.
URI: http://ahro.austin.org.au/austinjspui/handle/1/13768
DOI: 10.1002/jcph.753
ORCID: 0000-0002-7193-9723
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/27094014
Type: Journal Article
Subjects: Temozolomide
Liver Cirrhosis
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.